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Abstract
Background: Exertional heatstroke is a life-threatening condition with high mortality because of the rapid progress
of multiple organ dysfunction syndrome even if aggressive treatments are initiated rapidly. Mild to moderate
hepatic injury is common in exertional heatstroke, while fulminant liver failure is rare. Extrapyramidal symptoms and
pulmonary aspergillosis secondary to liver failure induced by exertional heatstroke have never been reported in
prior cases.
Case presentation: A 25-year-old Han Chinese man presented with exertional heatstroke with fulminant liver
failure, subsequent pulmonary aspergillosis, and extrapyramidal symptoms. Moreover, he also presented with coma,
rhabdomyolysis, acute kidney injury, and disseminated intravascular coagulation. He recovered under conservative
treatment including therapeutic plasma exchange plus continuous veno-venous hemofiltration, fluid resuscitation,
antibiotics, and other support therapy.
Conclusions: Therapeutic plasma exchange plus continuous veno-venous hemofiltration could be effective for
patients with heatstroke who suffer liver failure and other organ failure. Patients with liver failure are at high risk for
pulmonary aspergillosis. Movement disorder in these patients might be extrapyramidal symptoms induced by
consistent low level of cholinesterase resulted from hepatic injury besides brain injury.
Keywords: Case report, Heatstroke, Liver failure, Extrapyramidal symptoms, Pulmonary aspergillosis, Therapeutic
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Background
Heatstroke is clinically diagnosed as a severe elevation in
body temperature, central nervous system (CNS) dys-
function, and a history of environmental heat exposure
or vigorous physical exertion [1]. Classic heatstroke pri-
marily occurs in immunocompromised individuals dur-
ing annual heat waves. Exertional heatstroke (EHS) is
observed in individuals who are highly motivated to per-
form strenuous physical activity in hot weather [1]. To
date, the treatment for heatstroke is aggressive cooling,
fluid resuscitation, and other organ support therapy.
Despite these efforts, EHS mortality is high and is usu-
ally associated with multi-organ failure, especially hep-
atic injury and coagulopathy [2–4]. However, mild to
moderate hepatic injury is common in EHS, while ful-
minant liver failure has been reported only in about 5 %
of patients [5]. Emerging evidence suggests that multi-
organ damage is a consequence of direct thermal injury
to the tissues, coagulopathies, and development of a sys-
temic inflammatory response syndrome (SIRS) that is
stimulated by endotoxin, cytokines, and other immune
modulators. In this report, we describe the case of a 25-
year-old man who presented with EHS with fulminant
liver failure, subsequent pulmonary aspergillosis, and
extrapyramidal symptoms.* Correspondence: hujie0325@foxmail.com2Critical Care Medicine, Chinese PLA General Hospital, 28th Fuxing Road,
Haidian District, Beijing 100853, China
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Case presentation
A previously healthy 25-year-old Han Chinese man
started feeling dizzy after running 5 km on a rainy night
with an ambient temperature of about 30 °C. His surface
temperature was 41.2 °C (axillary) and he was taken to a
nearby hospital. On presentation at the hospital, he was
unconscious, with hyperpyrexia of 40.2 °C, tachycardia
of 129 beats/min, and blood pressure of 122/76 mmHg.
Orotracheal intubation was performed because of the
deterioration of his mental status. His initial blood tests
demonstrated elevated transaminases, bilirubin, creatine
kinase and creatinine, thrombocytopenia, and deteriorat-
ing coagulation. The patient was diagnosed as EHS and
multiple organ dysfunction syndrome (MODS). In spite
of cooling, aggressive fluid resuscitation and blood puri-
fication, hepatic and renal dysfunction continuously de-
teriorated. Therefore, the patient was transferred to our
critical care medical unit 5 days later (day 5). On admis-
sion, our patient was unconscious (no sedation, with a
Glasgow Coma Score (GCS) of 5) with mechanical venti-
lation. His temperature was 38.2 °C (axillary), heart rate
(HR) was 50 beats/min, respiratory rate (RR) was 15/
min, and his blood pressure (BP) was 103/70 mmHg
(norepinephrine 0.2ug/kg/min). Laboratory data revealed
worsened hepatic and renal function, deterioration of
coagulation parameters, and markers of infection. A cra-
nial and abdominal computed tomography (CT) scan
showed no abnormal findings; only the pulmonary CT
scan demonstrated little consolidation (Fig. 2a). An elec-
trocardiogram (ECG) revealed sinus bradycardia, pro-
longed QT interval and abnormal ST-T.
These biochemical disturbances reflected acute liver
failure (ALF). On admission (day 5), the results of his
blood biochemistry exhibited high transaminases, 1204.2
U/L alanine aminotransferase (ALT) (normal < 40 U/L),
363.9 U/L aspartate aminotransferase (AST) (normal <
40U/L), significantly elevated total bilirubin (TBIL)
47.0 mg/dL (normal < 1.16 mg/dL), and prothrombin
time-international normalized ratio (PT-INR) of 5.65,
decreased prothrombin activity (PTA) of 14 % (80 % <
normal < 130 %), fibrinogen of 1.16 g/L (2 g/L < normal
< 4 g/L) and cholinesterase of 4134U/L (ChE, 4650U/L
< normal < 12220U/L) (Fig. 1), and normal blood ammo-
nia of 100.7 μg/dL (27.2 μg/dL < normal < 102 μg/dL).
To exclude other causes for ALF, virus serological tests
were performed. There were no positive findings for
acute or chronic hepatitis A, B, C, E or human immuno-
deficiency virus (HIV). Also, acute infection with
Epstein-Barr virus (EBV) and cytomegalovirus (CMV)
was ruled out. The test results for autoimmune anti-
bodies (ASMA, AMA, ANA, ANCA, ENA) were nega-
tive. A past history review showed no recent mushroom
and herbal products ingestion, and no medication his-
tory. Moreover, our patient already met the ALF criteria
(TBIL 107.5umol/L and INR 3.1) outside our hospital
when his hemodynamic status was stable on day 2,
which could rule out hypoxic hepatitis. In addition,
an abdominal ultrasound and CT scan did not exhibit
evidence of dilated bile ducts and portal embolism.
Because of worsening hyperbilirubinemia, therapeutic
plasma exchange (TPE) was performed in the subse-
quent week, even though its role in ALF remained
unclear. With the fifth session, it was noted that our
patient was more responsive and started to open his
eyes spontaneously. His laboratory parameters were
also showing an improvement in liver function with
resolving coagulopathy (Fig. 1). TPE was discontinued
after six sessions and his TBIL decreased from then.
It is worth mentioning that his blood ammonia
remained normal during the whole process.
Our patient also suffered rhabdomyolysis with a creat-
ine kinase level of 10121U/L (CK, 2U/L < normal <
200U/L) with normal urine output and a mild increase
of creatinine because of adequate fluid resuscitation.
With the purpose of avoiding rhabdomyolysis-induced
acute kidney injury and alleviating SIRS, our patient re-
ceived continuous veno-venous hemofiltration (CVVH)
every day from day 5 to day 10. With the fifth session, it
was noted that his CK level (Fig. 1) declined gradually
and his creatinine level was normal.
Our patient presented persistent fever accompanied
with an increase of white blood cells (WBC) and neutro-
phils. On admission, his WBC count was 24,430/μL, N%
88 %, procalcitonin 2.11 ng/ml (normal < 0.5 ng/ml). A
sputum culture (day 14) showed Aspergillus and Acineto-
bacter baumannii. Considering liver failure could
dampen host immune function, caspofungin was added.
Subsequently, a pulmonary CT scan (day 23) demon-
strated emerging nodules with cavity (Fig. 2b). Thus pul-
monary aspergillosis was diagnosed even though the
galactomannan (GM) test was negative. A tracheotomy
was performed on day 29 not only to favor pulmonary
infection control but also to safely use sedative medica-
tion due to his undefined movement disorder. With an-
tifungal therapy and recovery of hepatic function, his
pulmonary infection improved and a pulmonary CT scan
(day 38) demonstrated nodules (Fig. 2c). He was success-
fully weaned from mechanical ventilation on day 34.
On day10, sedation was stopped to evaluate mental
status. The patient regained eyes open spontaneously
but experienced dystonia-like involuntary movements
of head and mouth but not extremities. At first, it
was diagnosed as seizures secondary to heatstroke re-
lated CNS dysfunction. However, we found that pro-
methazine could aggravate involuntary movements
while diazepam could temporarily mitigate the symp-
toms, which indicated that this might not be the case.
Electroencephalogram (day 52) showed no abnormal
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findings and cranial CT (day 4, 33) demonstrated at-
rophy of frontal lobe (Fig. 3a), temporal lobe (Fig. 3b)
and cerebellum (Fig. 3c), which might damage the con-
duction path of extrapyramidal system. What’s more, liver
failure induced consistent low ChE (Fig. 1), probably lead-
ing cholinergic and dopaminergic function disorder. Thus,
we believed that those involuntary movements were extra-
pyramidal symptoms. Benzhexol hydrochloride plus sco-
polamine therapy were initiated (day 53) and diazepam
managed to mitigate head and mouth movement disorder
even the patient was not sedated. As the recovery of hep-
atic function and increase of ChE, the dose of benzhexol
hydrochloride decreased.
Finally, at the time of discharge from the ICU (day 93),
our patient presented mental retardation, mild extrapyram-
idal symptoms, and his laboratory tests had returned to
normal values except for minor ALT elevation.
Discussion
In this case, we described a young patient with severe
EHS that was mainly complicated with fulminant liver fail-
ure and subsequent pulmonary aspergillosis and extrapyr-
amidal symptoms, as well as coma, rhabdomyolysis, acute
kidney injury, and disseminated intravascular coagulation.
The success in treating this EHS case suggested that
therapeutic plasma exchange (TPE) and CVVH might be
Fig. 1 Blood test results, including alanine transaminase (ALT), total bilirubin (TBIL), direct bilirubin (DBIL), prothrombin time-international normal-
ized ratio (PT-INR), creatine kinase (CK), and cholinesterase (ChE)
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effective in EHS cases with fulminant liver failure and
other organ failure.
Heatstroke is clinically diagnosed as a severe elevation
in body temperature that occurs in the presence of cen-
tral nervous system (CNS) dysfunction and a history of
environmental heat exposure or vigorous physical exer-
tion [1]. A retrospective study demonstrated that major
organ dysfunction involved in heat-related illness in-
cluded neurological (100 %), renal (57 %), hepatic
(34 %), and coagulation abnormalities (26 %) [6]. Ap-
proximately 5 % of EHS patients experienced fulminant
liver failure, which might be fatal [7]. However, accord-
ing to Kilian [8] and Garcin [9], acute liver failure (AHF)
is relatively frequent during heatstroke and the incidence
might be much higher than is usually thought, and
hypophosphatemia on admission could predict occur-
rence of ALF during heatstroke [9]. In this case, TBIL
was as high as 57.7 mg/dL (Fig. 1a, day 7) and PT was
as high as 52.2 seconds (day 5), which fulfilled accepted
London criteria [10] for emergency liver transplantation
(PT longer than 50 seconds, bilirubin higher than
17.5 mg/dL, and non-A, non-B hepatitis). The reason
that we still chose conservative therapy such as TPE
other than orthotopic liver transplantation (OLT) was as
follows: (1) the pathogenesis of liver failure might be dir-
ect thermo-injury to hepatic cells and overwhelming
SIRS, which could be conservatively managed and spon-
taneously recover [5, 11–13]; (2) the outcome of liver
transplantation in heatstroke in the previous case studies
was controversial [14, 15] but the immunosuppressor
might have aggravated sepsis-induced organ failure in
the mid or late phase in heatstroke [16]; (3) the coagu-
lopathy could be improved by transfusion or medication
while the blood ammonia levels were as high as
115.3 μg/dL on day 7 (27.2 μg/dL < normal < 102 μg/dL,
male). After TPE six times, the TBIL level decreased to
14.97 mg/dL (day 14) and the hepatic function recovered
spontaneously.
TPE can be used for thrombotic microangiopathy and
acute liver failure [17]. To date, only one study was ran-
domized and controlled in patients with ALF to demon-
strate a conclusive improvement with conservative
therapies [18]. Even whether TPE could treat ALF was
controversial, although some case reports have proved
Fig. 2 Computed tomography images of lung. a Computed tomography scan on day 4 showing no abnormality. b Computed tomography scan
on day 23 showing emerging nodules with cavity. c Computed tomography scan on day 38 showing narrowing nodules. Red arrows, cavity
Fig. 3 Computed tomography images of the brain showing atrophy of the temporal and frontal lobe and the cerebellum, comparing the
computed tomography scan on day 4 to the computed tomography scan on day 33
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that TPE might be effective in EHS with ALF. Raj et al.
demonstrated that the addition of therapeutic plasma
exchange plus continuous veno-venous hemodiafiltration
(CVVHDF) resulted in a reversal of the inflammatory
process and recovery from multi-organ failure in an 11-
year-old obese boy who suffered EHS with rhabdomyoly-
sis and concurrent renal, pulmonary, and liver failure
[13]. Miura et al. also demonstrated that a previously
healthy 38-year-old Japanese man who developed EHS
following a long-distance run and presented with ful-
minant hepatic failure (FHF) accompanied by a life-
threatening flare-up of rhabdomyolysis. Plasma exchange
and hemodiafiltration enabled the patient to survive
FHF [19]. In our case, like the young man in the former
case report [13], our patient finally recovered from ALF,
rhabdomyolysis, and concurrent renal and pulmonary
failure after TPE and CVVH therapy, which indicated
that TPE plus blood purification might be effective in
heatstroke with ALF, rhabdomyolysis, and other concur-
rent organ failure.
Encephalopathy is a universal manifestation of heat-
stroke, occurring abruptly, and can be severe in most of
the cases. Commonly, encephalopathy improves dramat-
ically by cooling in 70–90 % of heatstroke patients [20].
Those who did not regain consciousness by cooling or
initial therapies always developed seizures or focal motor
deficit [20]. The most conspicuous histological damage
to the CNS of heatstroke patients includes progressive
degeneration of neurons in the cerebellum and cerebral
cortex with congestion, edema, and microhemorrhages
at autopsy [1]. In this case, a cranial CT scan demon-
strated atrophy of the frontal lobe (Fig. 3a), temporal
lobe (Fig. 3b), and cerebellum (Fig. 3c), which could ex-
plain his mental retardation and extrapyramidal symp-
toms. In addition, benzhexol hydrochloride, a kind of
anticholinergic drug, managed to mitigate our patient’s
movement disorder, which confirmed the onset of extra-
pyramidal symptoms. To date, there has been no report
on heatstroke-induced extrapyramidal symptoms. Theor-
etically, consistent low ChE (Fig. 1) might exaggerate
cholinergic and dopaminergic function disorder in the
context of frontal atrophy. Moreover, as hepatic function
recovered and ChE level increased, the dose of benz-
hexol hydrochloride decreased. Thus, liver failure and
decreasing ChE might be involved in extrapyramidal
symptoms in this case.
SIRS plays an important role in heatstroke pathogen-
esis as sepsis. In that, early death might be due to over-
whelming inflammation while late death might be due to
persistent immunosuppression and irreversible infection
[21]. Tarek reported a 25-year-old man with heatstroke
presenting with severe rhabdomyolysis and massive hep-
atic necrosis, who died 41 days after the liver transplant-
ation of systemic infection due to fungal and bacterial
sepsis [16]. In this regard, prior case reports have docu-
mented a high prevalence of Candida spp. infections in
heatstroke victims [22]. Invasive pulmonary aspergillosis
(IPA) is a rapid, progressive, fatal disease that occurs
mostly in immunocompromised patients. It has been
previously demonstrated that patients with decompen-
sated liver disease are more prone to pulmonary asper-
gillosis [23, 24]. In this case, our patient exhibited high
fever, elevated WBC and PCT, aspergillus of sputum cul-
ture (day14), and emerging nodes on a pulmonary CT
scan (day 23), which indicated invasive pulmonary asper-
gillosis (IPA). Given the ALF and potential acute kidney
injury due to rhabdomyolysis, caspofungin rather than
voriconazole or amphotericin B (there was no liposomal
amphotericin in our hospital) was chosen as the first-
line treatment. Fortunately, caspofungin was able to con-
trol the above symptoms and thus was used as mono-
therapy in this patient with IPA.
Conclusions
In conclusion, we for the first time report an exertional
heatstroke case with liver failure complicated with unex-
pected extrapyramidal symptoms and pulmonary asper-
gillosis. Unlike other cases, the movement disorders
were induced by consistent low ChE level, which can ex-
aggerate cholinergic and dopaminergic function disorder
in the context of frontal atrophy. Thus, as to EHS pa-
tients with multiple organ dysfunction characterized by
fulminant liver failure, appropriate supportive therapy,
such as TPE and CVVH rather than liver transplantation
could be justified in the early stage and substantially re-
duce the mortality and thus was strongly recommended.
Anticholinergic drugs, such as benzhexol hydrochloride
or scopolamine, could mitigate movement disorders.
Further clinical research needs to weigh the risk of ful-
minant liver failure in EHS.
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